test

Robert Grundstein

@Sabby Management, Llc

Latest period2024 - Q3ReportedManaged Assets$186.418MTotal holdings42
Assets growth rate-99.87%Assets growth rate (2-Q avg)-57.03%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sabby Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.

Assets under management

The assets under management (AUM) of Sabby Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.418M in assets, with a quarterly growth rate of -99.87% and a 2-quarter average growth rate of -57.03%. The portfolio is managed by Robert Grundstein, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IMNNImunon Inc
Recent Activity
New Position
0.35%
$644,695
608,203 shares@ $1.06 avg price
2187⤦Core Scientific Inc
Recent Activity
Decreased -15.18%
0.27%
$496,934↑ Call
419 shares@ $1186.0 avg price
CORZCore Scientific Inc
Recent Activity
New Position
0.22%
$403,252
34,001 shares@ $11.87 avg price
1628⤦Checkpoint Therapeutics Inc
Recent Activity
Decreased -34.97%
0.22%
$394,464↓ Put
1,761 shares@ $224.0 avg price
PEGYPineapple Energy Inc
Recent Activity
New Position
0.2%
$372,688
2.779M shares@ $0.14 avg price
ENSCEnsysce Biosciences Inc
Recent Activity
Increased 269.84%
0.15%
$279,022
1.163M shares@ $0.24 avg price
SCPXScorpius Hldgs Inc
Recent Activity
New Position
0.14%
$249,304
346,256 shares@ $0.72 avg price
2862⤦Elevai Labs Inc
Recent Activity
New Position
0.12%
$210,968
2.542M shares@ $0.09 avg price
ATXIAvenue Therapeutics Inc
Recent Activity
Increased 68.64%
0.09%
$157,019
63,060 shares@ $2.49 avg price
SNESSenestech Inc
Recent Activity
New Position
0.08%
$143,549
55,639 shares@ $2.59 avg price